{{Rsnum
|rsid=4704560
|Chromosome=5
|position=79517927
|Orientation=plus
|GMAF=0.3526
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 30.1 | 51.3 | 18.6
| HCB | 5.1 | 41.6 | 53.3
| JPT | 6.2 | 32.7 | 61.1
| YRI | 0.7 | 10.9 | 88.4
| ASW | 3.5 | 35.1 | 61.4
| CHB | 5.1 | 41.6 | 53.3
| CHD | 11.9 | 41.3 | 46.8
| GIH | 33.7 | 58.4 | 7.9
| LWK | 0.0 | 18.3 | 81.7
| MEX | 8.6 | 50.0 | 41.4
| MKK | 2.6 | 28.2 | 69.2
| TSI | 37.3 | 49.0 | 13.7
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19648775
|Title=HOMER1 promoter analysis in Parkinson's disease: association study with psychotic symptoms
}}

{{PMID Auto
|PMID=20598711
|Title=Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}